Impact of Pelvic Exercise guidance on Urinary loss and pelvic Organ Falls
- Conditions
- Stress Urinary incontinenceWomenC12.777.934.852.249M01.975
- Registration Number
- RBR-4hz5vn
- Lead Sponsor
- niversidade Estadual de Campinas
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Women with urinary incontinence with predominance of stress urinary incontinence; Women who voluntarily accept and sign the Informed Consent Form (TCLE); Women who have a cell phone; Know how to read and write.
Neurological problems that compromise the understanding for the practice of exercises, or suggestive of neurogenic bladder; Diabetes Mellitus; Total absence of muscle contraction of the pelvic floor (P = 0); pelvic floor hypertonicity; Anterior surgery of the pelvic floor; Prolapse of pelvic organs greater than stage II; Use of local hormone; Proven or suspected pregnancy; Prior treatment for urinary incontinence; Three or more lower urinary tract infections in the last 12 months; Ultrasound image with poor resolution for analysis.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Expected outcome 1:Improvement in the urinary incontinence complaint, determined through the ICIQ UI-SF (International Consultation on Incontinence Questionnaire - Short Form), at the beginning of the study and at the end of the study.
- Secondary Outcome Measures
Name Time Method Expected outcome 2:Strength gain in the contraction of the pelvic floor muscles, assessed by digital palpation, with the modified OXFORD scale, after 6 months of treatment.;Expected outcome 3:Improvement in the human body limitation scores, psychosocial impact and social embarrassment due to urinary incontinence, evaluated by the I-QOL (Incontinence Quality of life Questionnaire) questionnaire, after 06 months of treatment.;Expected outcome 3:Greater thickness of the anus levator muscle, smaller area of the genital hiatus and urethral mobility, assessed by 3D translabial ultrasonography, after 6 months of treatment.